TolerRx, Inc.

Description

Tolerx is a biopharmaceutical company focused on the discovery, development, and commercialization of novel immunotherapies designed to reprogram the immune system and provide a long-term, durable remission after a short course of therapy. Tolerx has a development pipeline which includes two humanized antibodies that are in clinical trials for new-onset type 1 diabetes, psoriasis, and cutaneous lupus erythematosus. We also have ongoing research and development programs focused on generating new monoclonal antibody products for the treatment of immunological diseases.

Companies nearby